Person wearing a Lilly vest standing next to an Nvidia GPU
Biotech

Lilly debuts Nvidia supercomputer with fanfare and focus

The pharma industry is defined by high peaks and deep troughs, but Lilly's tech leaders hope that AI can help the drugmaker escape this brutal cycle.
Darren Incorvaia Feb 27, 2026 1:37pm
Wall Street IPO

Behind Generate's 'feverish' race to raise $400M IPO

Feb 27, 2026 3:36am
GettyImages-2217220002jpg

iRegene Dual Firsts: US Dosing in PD Phase IIa, China MSA Enrollment

Brought to you by iRegene Therapeutics
opening door to brick wall

Senate hearing takes aim at FDA's rare disease review process

Feb 26, 2026 3:50pm
Glowing puzzle piece fitting into puzzle

Earendil pens $885M pact to use WuXi XDC's linker tech for ADCs

Feb 27, 2026 5:30am
x

Fierce Biotech Layoff Tracker 2026: Merck, Viatris & more

Feb 27, 2026 2:45pm
More News

Atrium arises from Avidity buyout with $270M, preclinical assets

Feb 27, 2026 11:05am

Fierce Biotech Fundraising Tracker '26: Atrium, Breeze & more

Feb 27, 2026 9:00am

Sarepta CEO to step down as DM1 hits home—Chutes & Ladders

Feb 27, 2026 8:30am

Thermo Fisher unveils test for dosing of antirejection drug

Feb 27, 2026 5:20am